Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

S6B291 (S6B291_HUMAN) Homo sapiens (Human)

IgG H chain UniProtKBInterProInteractive Modelling

466 aa; Sequence (Fasta)

Available Structures

30 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Trastuzumab Fab v3 in complex with CQFDLSTRRLKC Heteromer
P01834; P02976; Q51918;
20-239
Assess
Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 Heteromer
P01834; P55285;
20-239
SIN;A2G;
Assess
Clostridium difficile TcdB-GTD bound to PA41 Fab Heteromer
Q8TCD0;
20-239
Assess
LINGO-1/Li81 Fab complex Heteromer
Q6PIL8; Q96FE5;
20-239
NAG;NAG;NAG;
Assess
Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and C… Heteromer
P0DOY2;
20-237
GOL;MG;
Assess
Trastuzumab Fab v3 Heteromer
P01834; P02976; Q51918;
20-237
Assess
Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A Heteromer
P0DOY2;
20-237
SO4;
Assess
Structure of cetuximab with aminoheptanoic acid-linked N-(3-aminopropyl)-L-arginine meditope variant Heteromer
P01834;
20-237
Assess
Structure of cetuximab with aminoheptanoic acid-linked N-carboxyethylarginine meditope variant Heteromer
P01834;
20-237
SO4;
Assess
Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant Heteromer
P01834;
20-237
SO4;
Assess
Structure of cetuximab with aminoheptanoic acid-linked n-octylarginine meditope variant Heteromer
P01834;
20-237
SO4;
Assess
DH717.1 Fab monomer in complex with man9 glycan Heteromer
Q6IPQ0;
20-237
MAN;GOL;
Assess
Crystal structure of anti-Zika antibody Z004 bound to DENV-1 Envelope protein DIII Heteromer
P0DOX7; Q8BE39;
20-237
Assess
CD22 d1-d3 in complex with therapeutic Fab Epratuzumab Heteromer
P20273; Q8TCD0;
20-237
NAG;NAG;
Assess
BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Heteromer
P01834; Q2N0S6; Q8TCD0;
20-237
10×NAG; 18×NAG;NAG;NAG;NAG;NAG; 13×NAG;
Assess
Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived … Heteromer
P04578; Q8TCD0;
20-236
NA;
Assess
Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived … Heteromer
P04578; Q8TCD0;
20-236
EDO;
Assess
Structure of cetuximab with aminoheptanoic acid-linked N-(3-hydroxypropyl)-L-arginine meditope vari… Heteromer
P01834;
20-236
SO4;
Assess
STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS Heteromer
P01834; P04578;
20-236
Assess
Crystal structure of Z032 Fab in complex with WNV EDIII Heteromer
P0DOX7; Q9Q6P4;
20-236
GOL;
Assess
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Heteromer
F5HCP3; F5HET4; P16837; Q68674; Q6GMX0; Q6SW67;
20-236
NAG; 10×NAG;
Assess
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin… Heteromer
Q2N0S6;
20-236
NAG;NAG; 18×NAG;NAG;NAG;NAG; 18×NAG;
Assess
BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195 Heteromer
P0DOX5; Q2N0S6; Q6GMW3; Q8TCD0;
20-236
Assess
Crystal structure of anti-Zika antibody Z006 bound to Zika virus envelope protein DIII Heteromer
A0A192GPS0; P0DOX7;
21-236
Assess
Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12… Heteromer
P01834; P01857; Q2N0S6;
21-236
12×NAG;NAG;NAG;NAG;NAG;NAG;NAG;NAG; 18×NAG;SO4;
Assess
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution data… Heteromer
F5HCP3; F5HET4; P16837; Q68674; Q6GMX0; Q6SW67;
20-234
NAG;NAG;
Assess
Crystal Structure of sErbB3-Fab3379 Complex Heteromer
P21860;
20-232
NAG;
Assess
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 Heteromer
F5HCP3; F5HET4; P16837; Q68674; Q6SW67; Q8TCD0;
20-232
NAG;NAG;NAG;
Assess
B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Heteromer
B3UES2; B3UEZ6; Q8N5F4;
20-137
NAG;NAG;NAG; 15×NAG;NAG;NAG; 33×NAG;
Assess
Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Heteromer
A0A2H4K974; Q8TCD0;
21-137
NAG; 26×NAG;NAG;NAG;NAG;NAG;NAG;NAG;NAG; 21×NAG;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7elx.1.Amonomer0.8020-236
93.99
Assess
8a64.1.Bmonomer0.69256-462
92.17
Assess